Stocks DASH Financial statements
Financial statementsDoorDash, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data DoorDash, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 291 | 885 | 2,886 | 4,888 | 6,583 | 8,635 | 10,722 | 13,717 |
| Cost of revenue | 228 | 523 | 1,368 | 2,338 | 3,588 | 4,589 | 5,542 | 6,738 |
| Gross profit | 63 | 362 | 1,518 | 2,550 | 2,995 | 4,046 | 5,180 | 6,979 |
| Research and development | 51 | 107 | 321 | 430 | 829 | 1,003 | 1,168 | 1,431 |
| Selling and marketing | 135 | 594 | 957 | 1,619 | 1,682 | 1,876 | 2,037 | 2,476 |
| General and administrative | 78 | 245 | 556 | 797 | 1,147 | 1,235 | 1,452 | 1,600 |
| Operating income | -210 | -616 | -436 | -452 | -1,124 | -579 | -38 | 723 |
| Interest expense | 1 | 0 | 32 | 14 | 2 | |||
| Other non-operating income | 0 | -68 | 3 | 0 | -305 | -107 | -5 | 5 |
| Pre-tax income | -204 | -666 | -458 | -463 | -1,399 | -534 | 156 | 939 |
| Income tax | 0 | 1 | 3 | 5 | -31 | 31 | 39 | 7 |
| Net income to minority interests | 0 | 0 | -3 | -7 | -6 | -3 | ||
| Net income | -204 | -667 | -461 | -468 | -1,365 | -558 | 123 | 935 |
| EBITDA | -201 | -584 | -316 | -296 | -755 | -70 | 523 | 1,470 |
| EPS, basic | -4.67 | -15.44 | -7.39 | -1.39 | -3.68 | -1.42 | 0.30 | 2.19 |
| EPS, diluted | -4.67 | -15.44 | -7.39 | -1.39 | -3.68 | -1.42 | 0.29 | 2.13 |
| Shares, basic (weighted) | 44.3 | 43.3 | 62.4 | 337 | 371 | 393 | 412 | 427 |
| Shares, diluted (weighted) | 44.3 | 43.3 | 62.4 | 337 | 371 | 393 | 430 | 440 |
Balance sheet
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 215 | 257 | 4,345 | 2,504 | 1,977 | 2,656 | 4,019 | 4,378 |
| Short-term investments | 508 | 514 | 1,253 | 1,544 | 1,422 | 1,322 | 1,128 | |
| Receivables | 58 | 291 | 349 | 400 | 533 | 732 | 1,108 | |
| Other current assets | 125 | 221 | 139 | 358 | 146 | 253 | 397 | |
| Total current assets | 998 | 5,517 | 4,565 | 4,720 | 5,597 | 7,386 | 8,643 | |
| Property, plant and equipment | 101 | 210 | 402 | 637 | 712 | 778 | 1,067 | |
| Lease right-of-use assets | 166 | 203 | 336 | 436 | 436 | 389 | 437 | |
| Goodwill | 0 | 306 | 316 | 316 | 2,370 | 2,432 | 2,315 | 5,519 |
| Intangible assets | 103 | 74 | 61 | 765 | 659 | 510 | 2,260 | |
| Long-term investments | 0 | 650 | 397 | 583 | 835 | 837 | ||
| Other non-current assets | 28 | 33 | 68 | 129 | 420 | 632 | 896 | |
| Total assets | 1,732 | 6,353 | 6,809 | 9,789 | 10,839 | 12,845 | 19,659 | |
| Accounts payable | 20 | 80 | 161 | 157 | 216 | 321 | 397 | |
| Accrued liabilities | 345 | 943 | 1,573 | 2,332 | 3,126 | 4,049 | 5,645 | |
| Deferred revenue | 13 | 108 | 183 | 251 | 308 | 396 | 547 | |
| Total current liabilities | 382 | 1,402 | 1,760 | 2,544 | 3,410 | 4,438 | 6,147 | |
| Lease liabilities | 167 | 238 | 373 | 456 | 454 | 468 | 461 | |
| Other non-current liabilities | 1 | 13 | 9 | 21 | 162 | 129 | 281 | |
| Total liabilities | 550 | 1,653 | 2,142 | 3,021 | 4,026 | 5,035 | 9,613 | |
| Paid-in capital | 70 | 6,313 | 6,752 | 10,633 | 11,887 | 13,165 | 14,092 | |
| Retained earnings | -1,152 | -1,613 | -2,081 | -3,846 | -5,154 | -5,255 | -4,320 | |
| Other comprehensive income | 0 | -4 | -33 | 73 | -107 | 261 | ||
| Shareholders' equity | -436 | -1,082 | 4,700 | 4,667 | 6,754 | 6,806 | 7,803 | 10,033 |
| Total equity | -436 | -1,082 | 4,700 | 4,667 | 6,754 | 6,806 | 7,803 | 10,033 |
| Total liabilities and equity | 1,732 | 6,353 | 6,809 | 9,789 | 10,839 | 12,845 | 19,659 |
Cash flow statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|
| Net income | -204 | -667 | -461 | -468 | -1,368 | -565 | 117 | 932 |
| Depreciation and amortization | 9 | 32 | 120 | 156 | 369 | 509 | 561 | 747 |
| Stock-based compensation | 24 | 18 | 322 | 486 | 889 | 1,088 | 1,099 | 1,051 |
| Deferred income tax | 0 | 1 | -35 | -1 | 1 | -37 | ||
| Change in receivables | -17 | -40 | -248 | -94 | -33 | -141 | -222 | -359 |
| Change in payables | 25 | -13 | 54 | 79 | -15 | 70 | 82 | 54 |
| Cash from operations | -159 | -467 | 252 | 692 | 367 | 1,673 | 2,132 | 2,431 |
| Capital expenditures | -13 | -78 | -106 | -129 | -176 | -123 | -104 | -257 |
| Acquisitions | 0 | -315 | -28 | 0 | 71 | 0 | 0 | -4,151 |
| Purchases of investments | -390 | -762 | -593 | -2,344 | -1,948 | -1,946 | -1,951 | -1,376 |
| Sales and maturities of investments | 49 | 440 | 583 | 720 | 1,552 | 1,940 | 1,774 | 1,379 |
| Cash from investing | -357 | -570 | -192 | -2,047 | -300 | -342 | -444 | -4,391 |
| Debt issued | 0 | 0 | 2,720 | |||||
| Stock issued | 5 | 3 | 5 | 32 | 11 | 6 | 14 | 9 |
| Share buybacks | -60 | 0 | 0 | 0 | -400 | -750 | -224 | 0 |
| Cash from financing | 666 | 1,109 | 3,996 | -483 | -375 | -752 | -204 | 2,360 |
| Exchange rate effect | 0 | 0 | 2 | -1 | -10 | 5 | -35 | 60 |
| Net change in cash | 150 | 72 | 4,058 | -1,839 | -318 | 584 | 1,449 | 460 |
| Free cash flow | -172 | -545 | 146 | 563 | 191 | 1,550 | 2,028 | 2,174 |
| Interest paid | 0 | 0 | 42 | 0 | 0 | |||
| Income taxes paid | 0 | 1 | 4 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 51.4% | Gross profit / revenue. |
| Operating margin | 4.5% | Operating income / revenue. |
| EBITDA margin | 10.8% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 5.5% | Pre-tax income / revenue. |
| Net margin | 5.3% | Net income / revenue. |
| FCF margin | 16.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 17.8% | Cash from operations / revenue. |
| Effective tax rate | 3.5% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 8.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 4.3% | Net income / average total assets. |
| Return on invested capital (ROIC) | 12.5% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 10.7% | Research and development expense / revenue. |
| Stock-based pay / revenue | 7.0% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.5% | Capital expenditures / revenue. |
| D&A / revenue | 6.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 27.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 27.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 36.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 34.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 32.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 35.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 181.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Net income growth, 1y | 660.2% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | 634.5% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | 14.0% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 87.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 57.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 7.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 124.9% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 71.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 28.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 14.1% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 16.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 53.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 26.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 25.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 2.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 5.8% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 47.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.37x | Current assets / current liabilities. |
| Quick ratio | 1.05x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.87x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 49.2% | Total liabilities / total assets. |
| Working capital | $2.26B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 38.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $2.42B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.81x | Revenue / average total assets. |
| Fixed asset turnover | 12.8x | Revenue / average property, plant and equipment. |
| Receivables turnover | 14.4x | Revenue / average receivables. |
| Days sales outstanding | 25 days | 365 x average receivables / revenue. |
| Days payables | 14 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 308.6% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 8.3% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $1.91 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $36.17 | Revenue / diluted weighted shares. |
| FCF per share | $5.91 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $6.44 | Cash from operations / diluted weighted shares. |
| Book value per share | $22.58 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $5.51 | Tangible book value / shares outstanding. |
| Cash per share | $12.17 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 40.4% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $83.78B | Share price x shares outstanding. |
| Enterprise value | $78.44B | Market cap + total debt - cash - short-term investments. |
| P/E | 99.6x | Market cap / net income. Only when net income is positive. |
| P/S | 5.27x | Market cap / revenue. |
| P/B | 8.44x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 34.6x | Market cap / tangible book value, when positive. |
| P/FCF | 32.3x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 29.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 4.94x | Enterprise value / revenue. |
| EV/EBIT | 110x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 45.8x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 30.2x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 3.1% | Free cash flow / market cap. |
| Earnings yield | 1.0% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 1.3% | (Dividends paid + share buybacks) / market cap. |
What was DoorDash, Inc.'s revenue in fiscal 2025?
DoorDash, Inc. reported revenue of $13.72B for fiscal 2025, 27.9% higher than the year before.
Was DoorDash, Inc. profitable in fiscal 2025?
Yes. Net income was $935.0M, a net margin of 6.8%.
How much free cash flow did DoorDash, Inc. generate in fiscal 2025?
Cash from operations of $2.43B minus capital expenditures of $257.0M left free cash flow of $2.17B.